Natixis Advisors, L.P. Medpace Holdings, Inc. Transaction History

Natixis Advisors, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$109.38 - $149.19 $1.86 Million - $2.54 Million	-17,034 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$92.95 - $130.61 $203,839 - $286,427	-2,193 Reduced 11.41%	17,034 $1.9 Million
Q2 2020 Aug 11, 2020	BUY	$68.08 - $95.68 $8,850 - $12,438	130 Added 0.68%	19,227 $1.79 Million
Q1 2020 Apr 27, 2020	BUY	$61.71 - $101.95 $1.18 Million - $1.95 Million	19,097 New	19,097 $1.4 Million

622

25.1M

154K

117K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.